Troponin I antibody and reagents for proteins in isoforms and in circulation

Choosing and handling

1. Name the isoform for muscle targets. Cardiac, skeletal and smooth muscle isoforms of the same protein family differ in a small number of residues. A reagent that does not state which it detects cannot support a tissue specific claim.
2. Extract muscle properly. Very large and highly cross linked muscle proteins need specialised gels and extraction, and standard sample preparation leaves them at the top of the well. Use a protocol designed for the size range.
3. Treat abundant plasma proteins as a dilution problem. Highly abundant analytes saturate immunoassays and mask everything else. Dilution series, depletion where appropriate and a clear statement of the dilution used are what make these measurements comparable.
4. Standardise blood collection. Tube type, time to processing, temperature and freeze thaw change measured concentrations, sometimes by more than the biological effect. Fix the collection protocol before the first sample.
5. Do not assume a loading control is stable. Common structural loading references change with differentiation, stress and tissue type. Total protein staining is safer, and should be shown.

Isoforms are separate proteins in practice

Sequence similarity between tissue specific isoforms is high enough that many polyclonal reagents see all of them. That is fine when the tissue is known and fatal when the point is to identify the tissue of origin.

Where tissue specificity is the claim, use a monoclonal with a stated discrimination and show it on both tissues.

Abundance changes the technique

For a protein present at high concentration, the limiting factor is never sensitivity. It is linearity, dilution accuracy and whether the assay saturates, and the useful validation is a dilution series on real samples rather than a standard curve in buffer.

Report the dilution and show that the result is dilution independent. That single check catches most of the errors in this area.

A galectin 3 antibody and a marker read in two fields

Galectin-3 is measured as a cardiac and fibrosis biomarker in serum and stained as a marker in thyroid pathology, so a galectin 3 antibody may be sold for either and the validated application decides which claim it supports. The protein is secreted as well as intracellular, so the sample type changes what is being measured, and an assay's calibration belongs in any reported concentration.

A gdf15 antibody and a stress cytokine

GDF15 rises with cellular stress and with several diseases, so a gdf15 antibody is used mostly in immunoassays on plasma rather than on tissue. The protein circulates as a mature dimer cleaved from a precursor, so the form the assay detects is the question, and assays have disagreed historically for that reason. A stated standard and calibration are what make a figure comparable.

An nt5c1a antibody and an autoantibody target

NT5C1A matters mainly as the antigen of an autoantibody used in inclusion body myositis, so the reagent bought is usually the antigen or an assay rather than a detection antibody, and an nt5c1a antibody in a catalogue detects the enzyme in tissue instead. Sensitivity and specificity of the autoantibody test are the clinically reported numbers, not the antibody's affinity.

A jo1 antibody and the antigen behind the name

The Jo-1 autoantibody recognises histidyl transfer RNA synthetase, so a jo1 antibody in a catalogue is either the antigen for an assay or a reagent against that enzyme. Its clinical use is in myositis panels where the pattern of autoantibodies rather than any single result carries the interpretation, which is why these assays are sold and read as panels.

A crest antibody and what the acronym names

A crest antibody means an anticentromere antibody, named for the syndrome it is associated with, so a catalogue search on the acronym and one on the antigen return the same clinical test under two names. The laboratory reading is a nuclear pattern on indirect immunofluorescence confirmed by a specific assay, which is why the pattern and the confirmation are reported together.

An alpha 1 antitrypsin antibody and the serum assay around it

An alpha 1 antitrypsin antibody reports a serum protease inhibitor measured to find a deficiency, so the assay needs a calibrator traceable to a reference material rather than a relative signal. The antibody must see the common deficiency variants as well as the normal protein, or a deficient sample reads as merely low.

Common questions

Does a troponin reagent distinguish cardiac from skeletal?

Only if it says so. The isoforms differ at defined regions and clones vary in whether they discriminate. For any tissue specific claim the datasheet must state it explicitly.

Why does my very large muscle protein not enter the gel?

Standard acrylamide gels do not resolve proteins of that size. Low percentage or gradient gels designed for the range, and a gentler extraction, are required.

How much does blood collection matter for a BNP antibody assay?

Frequently more than the biology. Tube additive, time to processing and freeze thaw all change measured concentrations for several plasma analytes, which is why a fixed protocol comes before the first sample.

Browse by service class

• Compare Gene synthesis on advertised prices